These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24599112)

  • 41. Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age.
    Tourrel C; Bailbé D; Meile MJ; Kergoat M; Portha B
    Diabetes; 2001 Jul; 50(7):1562-70. PubMed ID: 11423477
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Graft revascularization is essential for non-invasive monitoring of transplanted islets with radiolabeled exendin.
    Eter WA; Bos D; Frielink C; Boerman OC; Brom M; Gotthardt M
    Sci Rep; 2015 Oct; 5():15521. PubMed ID: 26490110
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Decreased VMAT2 in the pancreas of humans with type 2 diabetes mellitus measured in vivo by PET imaging.
    Cline GW; Naganawa M; Chen L; Chidsey K; Carvajal-Gonzalez S; Pawlak S; Rossulek M; Zhang Y; Bini J; McCarthy TJ; Carson RE; Calle RA
    Diabetologia; 2018 Dec; 61(12):2598-2607. PubMed ID: 29721633
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antidiabetic actions of endogenous and exogenous GLP-1 in type 1 diabetic patients with and without residual β-cell function.
    Kielgast U; Holst JJ; Madsbad S
    Diabetes; 2011 May; 60(5):1599-607. PubMed ID: 21441444
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ex vivo imaging of pancreatic beta cells using a radiolabeled GLP-1 receptor agonist.
    Connolly BM; Vanko A; McQuade P; Guenther I; Meng X; Rubins D; Waterhouse R; Hargreaves R; Sur C; Hostetler E
    Mol Imaging Biol; 2012 Feb; 14(1):79-87. PubMed ID: 21394533
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Non-invasive glucagon-like peptide-1 receptor imaging in pancreas with (18)F-Al labeled Cys(39)-exendin-4.
    Mi B; Xu Y; Pan D; Wang L; Yang R; Yu C; Wan W; Wu Y; Yang M
    Biochem Biophys Res Commun; 2016 Feb; 471(1):47-51. PubMed ID: 26850848
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exendin-4, a glucagon-like peptide-1 receptor agonist, inhibits cell apoptosis induced by lipotoxicity in pancreatic β-cell line.
    Wei Q; Sun YQ; Zhang J
    Peptides; 2012 Sep; 37(1):18-24. PubMed ID: 22776329
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 64Cu- and 68Ga-labelled [Nle(14),Lys(40)(Ahx-NODAGA)NH2]-exendin-4 for pancreatic beta cell imaging in rats.
    Mikkola K; Yim CB; Fagerholm V; Ishizu T; Elomaa VV; Rajander J; Jurttila J; Saanijoki T; Tolvanen T; Tirri M; Gourni E; Béhé M; Gotthardt M; Reubi JC; Mäcke H; Roivainen A; Solin O; Nuutila P
    Mol Imaging Biol; 2014 Apr; 16(2):255-63. PubMed ID: 24101374
    [TBL] [Abstract][Full Text] [Related]  

  • 49. β-Cell mass imaging with DTBZ positron emission tomography: is it possible?
    Blomberg BA; Eriksson O; Saboury B; Alavi A
    Mol Imaging Biol; 2013 Feb; 15(1):1-2. PubMed ID: 22983914
    [No Abstract]   [Full Text] [Related]  

  • 50. GLP-1 and exendin-4 for imaging endocrine pancreas. A review. Labelled glucagon-like peptide-1 analogues: past, present and future.
    Hubalewska-Dydejczyk A; Sowa-Staszczak A; Tomaszuk M; Stefańska A
    Q J Nucl Med Mol Imaging; 2015 Jun; 59(2):152-60. PubMed ID: 25719487
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 11C-dihydrotetrabenazine PET of the pancreas in subjects with long-standing type 1 diabetes and in healthy controls.
    Goland R; Freeby M; Parsey R; Saisho Y; Kumar D; Simpson N; Hirsch J; Prince M; Maffei A; Mann JJ; Butler PC; Van Heertum R; Leibel RL; Ichise M; Harris PE
    J Nucl Med; 2009 Mar; 50(3):382-9. PubMed ID: 19223416
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A nanobody-based nuclear imaging tracer targeting dipeptidyl peptidase 6 to determine the mass of human beta cell grafts in mice.
    Demine S; Garcia Ribeiro R; Thevenet J; Marselli L; Marchetti P; Pattou F; Kerr-Conte J; Devoogdt N; Eizirik DL
    Diabetologia; 2020 Apr; 63(4):825-836. PubMed ID: 31873789
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dapagliflozin promotes beta cell regeneration by inducing pancreatic endocrine cell phenotype conversion in type 2 diabetic mice.
    Wei R; Cui X; Feng J; Gu L; Lang S; Wei T; Yang J; Liu J; Le Y; Wang H; Yang K; Hong T
    Metabolism; 2020 Oct; 111():154324. PubMed ID: 32712220
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Synthetic Heterobivalent Ligand Composed of Glucagon-Like Peptide 1 and Yohimbine Specifically Targets β Cells Within the Pancreas.
    Steyn LV; Ananthakrishnan K; Anderson MJ; Patek R; Kelly A; Vagner J; Lynch RM; Limesand SW
    Mol Imaging Biol; 2015 Aug; 17(4):461-70. PubMed ID: 25604385
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo imaging of the glucagonlike peptide 1 receptor in the pancreas with 68Ga-labeled DO3A-exendin-4.
    Selvaraju RK; Velikyan I; Johansson L; Wu Z; Todorov I; Shively J; Kandeel F; Korsgren O; Eriksson O
    J Nucl Med; 2013 Aug; 54(8):1458-63. PubMed ID: 23761918
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bioactive GLP-1 in gut, receptor expression in pancreas, and insulin response to GLP-1 in diabetes-prone rats.
    Valverde I; Wang GS; Burghardt K; Kauri LM; Redondo A; Acitores A; Villanueva-Peñacarrillo ML; Courtois P; Sener A; Cancelas J; Malaisse WJ; Scott FW
    Endocrine; 2004 Feb; 23(1):77-84. PubMed ID: 15034199
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synergy Between Gαz Deficiency and GLP-1 Analog Treatment in Preserving Functional β-Cell Mass in Experimental Diabetes.
    Brill AL; Wisinski JA; Cadena MT; Thompson MF; Fenske RJ; Brar HK; Schaid MD; Pasker RL; Kimple ME
    Mol Endocrinol; 2016 May; 30(5):543-56. PubMed ID: 27049466
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Species differences in pancreatic binding of DO3A-VS-Cys
    Eriksson O; Rosenström U; Selvaraju RK; Eriksson B; Velikyan I
    Acta Diabetol; 2017 Nov; 54(11):1039-1045. PubMed ID: 28891030
    [TBL] [Abstract][Full Text] [Related]  

  • 59. GLP-1 receptor antagonist as a potential probe for pancreatic beta-cell imaging.
    Mukai E; Toyoda K; Kimura H; Kawashima H; Fujimoto H; Ueda M; Temma T; Hirao K; Nagakawa K; Saji H; Inagaki N
    Biochem Biophys Res Commun; 2009 Nov; 389(3):523-6. PubMed ID: 19737540
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.
    Göke R; Fehmann HC; Linn T; Schmidt H; Krause M; Eng J; Göke B
    J Biol Chem; 1993 Sep; 268(26):19650-5. PubMed ID: 8396143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.